Clinical Manifestations of Gastrointestinal Granulocytic Sarcoma Requiring Surgical Treatment

Zhou, Wei; Vasquez, Julio C.; O'Donnell, Margaret R.; Paz, Benjamin I.
August 2001
American Surgeon;Aug2001, Vol. 67 Issue 8, p764
Academic Journal
Granulocytic sarcoma is a rare extramedullary soft-tissue tumor of granulocytic lineage with an incidence of 3 to 5 per cent in patients with acute myelogenous leukemia. The most common sites of involvement are bone, soft tissue, lymph nodes, and skin. Here we report three unusual cases of granulocytic sarcoma involving the gastrointestinal tract that required surgical intervention.


Related Articles

  • Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions. Bauer, Sebastian; Joensuu, Heikki // Drugs;Aug2015, Vol. 75 Issue 12, p1323 

    Imatinib is strongly positioned as the recommended first-line agent for most patients with advanced gastrointestinal stromal tumor (GIST) due to its good efficacy and tolerability. Imatinib-resistant advanced GIST continues to pose a therapeutic challenge, likely due to the frequent presence of...

  • Clear Cell Sarcoma and Osteoclast-Rich Clear Cell Sarcoma-Like Tumor of the Gastrointestinal Tract: One Tumor Type or Two? Melanoma or Sarcoma? Rosai, Juan // International Journal of Surgical Pathology;Oct2005, Vol. 13 Issue 4, p309 

    Comments on clear cell sarcoma and osteoclast-rich clear cell sarcoma-like tumor of the gastrointestinal tract. Awareness that many of the tumor types that had been previously identified on morphologic grounds are linked with specific or quasi-specific cytogenetic alterations; Indication that no...

  • Pathogenetic mechanisms in endometrial stromal sarcoma. Micci, F.; Heim, S. // Cytogenetic & Genome Research;2007, Vol. 118 Issue 2-4, p190 

    The article presents a clinical study on pathogenetic mechanisms in endometrial stromal sarcoma (ESS) in the U.S. It is stated that a different approach to detect pathogenetic mechanisms operative in endometrial stromal tumors (EST) found a variety of gains and losses that apparently did not...

  • Clear cell sarcoma of tendons and aponeuroses, and osteoclast-rich tumour of the gastrointestinal tract with features resembling clear cell sarcoma of soft parts: a review and update.  // Journal of Clinical Pathology;May2010, Vol. 63 Issue 5, p416 

    The article discusses the historical, histopathological, ultrastructural, immunohistochemical and genetic features of clear cell sarcoma (CCS) of tendons and aponeuroses and osteoclast-rich tumor of the gastrointestinal tract with features resembling CCS of soft parts (CCSLGT). CCS has...

  • Cystosarcoma Phyllodes and Gastrointestinal Stromal Tumors: Birds of the Same Feather? Vattipally, Vikram R.; Raman, Shankar R.; Pokala, Naveen; Ungsunan, Pituck // American Surgeon;Feb2012, Vol. 78 Issue 2, pE109 

    The article describes the case of a 70-year-old woman with fribroadenoma, cystosarcoma phyllodes tumor as well as gastrointestinal tumor of the stomach. The patient presented with a 5-month history of a painful mass in the left breast. Her physical examination revealed a large mass with...

  • Gastrointestinal stromal tumour with a KIT exon 11 mutation presenting as a paratesticular mass. HILMAN, S.; SOTHI, S.; PEAKE, D.; ANDERSSON, J.; MEIS, J. M. // British Journal of Radiology;May2009, Vol. 82 Issue 977, pe98 

    Gastrointestinal stromal tumours (GISTs) are sarcomas arising in the gastrointestinal tract. They are characterised by a gain in function mutation of the KIT oncogene and the majority express the receptor tyrosine kinase KIT, which can be detected by the immunohistochemical stain CD117. Patients...

  • Voluminous gastric fibrosarcoma in a 75-year-old patient. Carcano, Giulio; Frattini, Francesco; Puricelli, Marco // BMC Geriatrics;2009 Supplement 1, Vol. 9, Special section p1 

    Background Gastrointestinal stromal tumors are mesenchymal neoplasms of the gastrointestinal tract, arising from the muscular layer. Revent immunohistochemical studies have shown that up to 94% of GISTs express 117, and 60-70% of GISTs stain for CD 34. GISTs account for 1% of all malignant...

  • Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy. Annaberdyev, Shohrat; Gibbons, Joseph; Hardacre, Jeffrey M. // World Journal of Surgical Oncology;2009, Vol. 7, p1 

    Gastrointestinal stromal tumors (GISTs) are the most common sarcoma of the alimentary tract and are believed to derive from the interstitial Cell of Cajal. Imatinib mesylate (Gleevec®; Novartis, Basel, Switzerland) has revolutionized the treatment of GISTs and is generally used in the...

  • Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs. Emile, J.; Brahimi, S.; Coindre, J.; Bringuier, P.; Monges, G.; Samb, P.; Doucet, L.; Hostein, I.; Landi, B.; Buisine, M.; Neuville, A.; Bouché, O.; Cervera, P.; Pretet, J.; Tisserand, J.; Gauthier, A.; Cesne, A.; Sabourin, J.; Scoazec, J.; Bonvalot, S. // Medical Oncology;Sep2012, Vol. 29 Issue 3, p1765 

    Gastrointestinal stromal tumors (GISTs) are the most common human sarcoma. Most of the data available on GISTs derive from retrospective studies of patients referred to oncology centers. The MolecGIST study sought to determine and correlate clinicopathological and molecular characteristics of...

  • PET for Sarcomas Other Than Gastrointestinal Stromal Tumors. Toner, Guy C.; Hicks, Rodney J. // Oncologist;Apr2008 Supplement 2, Vol. 13, p22 

    Positron emission tomography (PET) is increasingly used to diagnose, grade, and stage different types of tumors and to assess tumor response to therapy. Metabolic data acquired by fluorine-18-fluorodeoxyglucose (18FDG)-PET may facilitate accurate grading of sarcomas and have prognostic value...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics